Innocan Pharma INNPF
OTC INNPF
$1.29 +0.00 (+0.00%)
At close: Nov 12, 2026 · 4:00 PM EST

Innocan Pharma (INNPF) Net Debt Issuances and Repayments (2025)

Updated

Innocan Pharma's Net Debt Issuances and Repayments came in at $640,000 for the year ended Dec 31, 2025.

Analysis

Innocan Pharma (INNPF) Net Debt Issuances and Repayments (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -5.28 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.28 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 9.48 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -682.00 Mn
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 4.91 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -19.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -87.00 Mn
10 Innocan Pharma 5.78 Mn 1.73 Mn 4.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 640,000.00
API Access

Innocan Pharma Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=INNPF&period=max&api_key=YOUR_API_KEY